What substances is Vivitrol used to treat?

Vivitrol is primarily used to treat opioid use disorder and alcohol use disorder because the medication affects opioid receptors involved in reward signaling, reinforcement, and substance-related craving pathways. The medication contains extended-release naltrexone, which functions as an opioid receptor antagonist. By blocking opioid receptors, Vivitrol reduces the ability of opioids to produce euphoric effects and may reduce reinforcing effects associated with alcohol use.

In opioid use disorder treatment, Vivitrol is used after complete opioid detoxification because opioid receptor blockade can precipitate severe withdrawal symptoms if opioids are still present in the body. The medication is intended to reduce relapse vulnerability by blocking the rewarding effects of opioid use. Its mechanism differs from methadone and buprenorphine, which activate opioid receptors to varying degrees.

In alcohol use disorder treatment, Vivitrol may help reduce reinforcement associated with drinking by affecting reward-related neurological pathways involving endogenous opioid signaling and dopamine release. Although the medication does not produce intoxication or withdrawal suppression in alcohol dependence, it may influence craving intensity and alcohol-related reward responses in some individuals.

Vivitrol is not currently approved as a primary medication-assisted treatment for stimulant use disorders involving cocaine or methamphetamine. It is also not generally used as a standalone treatment for cannabis use disorder or nicotine dependence. Different substance categories involve different neurobiological mechanisms that may respond differently to pharmacological treatment.

The use of Vivitrol is generally based on its ability to block opioid receptor activity and alter addiction-related reward signaling. Treatment suitability may depend on opioid detoxification status, medical conditions, psychiatric symptoms, relapse history, and overall recovery goals. Vivitrol is commonly used within medication-assisted treatment frameworks for opioid and alcohol use disorders.